Phase 1 N=175 Randomized Single-blind Supportive Care

Rehabilitation of Patients After THR - Based on Patients´Selfrated Health

Total Hip Replacement

Bottom Line

View on ClinicalTrials.gov: NCT02644096 ↗

Enrolled (actual)

175

Serious AEs

0.0%

Results posted

Jun 2016

Primary outcome: Primary: Change in Physical Dimensions in Health Status of Elderly Patients From 4 Weeks Pre Operatively to 9 Months Post Operatively After THR. Health Status is Measured by the Questionnaire Short-form 36 (SF-36). — 9.6; 17.8; 1.2; 7.3 Scores on SF-36 questionnaires — p=<0.05

Study Design & Population

Study type: Interventional
Phase: Phase 1
Interventions: counselling and support after discharge from hospital (Other)
Age: Older Adult · 65+ yrs
Sex: All
Sponsor: University of Aarhus
Primary completion: Sep 2007

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Physical Dimensions in Health Status of Elderly Patients From 4 Weeks Pre Operatively to 9 Months Post Operatively After THR. Health Status is Measured by the Questionnaire Short-form 36 (SF-36).	9.6; 17.8; 1.2; 7.3; 4.2; 11.1	<0.05 sig

Summary

Objective: The investigators hypothesized that all areas of health status after total hip replacement could be improved in patients aged over 65 years and over by using telephone support and counselling 2 and 10 weeks after surgery compared with a control group receiving conventional care and treatment. Design: A randomised clinical trial focusing on patients' health status by using SF-36 at 4 weeks pre- and 3 and 9 months postoperatively was carried out. Sample: 180 patients aged 65 and over were randomised 4 weeks preoperatively to either control or intervention groups. Measurements: Both groups received conventional surgical treatment, but the intervention group was interviewed by telephone 2 and 10 weeks after surgery. Patients were given counselling within eight main dimensions with reference to their postoperative situation. Key-words: THR - elderly patients - health status - postoperative support - counselling

Eligibility Criteria

Inclusion Criteria

Patients enrolled to THR
Being able to read and understand Danish

Exclusion Criteria

Patients not being able to participate or refused
Any condition that makes the subject unable to participate in the opinion of the investigator.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02644096). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.